Guangzheng Eye Hospital GroupLtd Past Earnings Performance
Past criteria checks 0/6
Guangzheng Eye Hospital GroupLtd's earnings have been declining at an average annual rate of -42.7%, while the Healthcare industry saw earnings growing at 2% annually. Revenues have been declining at an average rate of 4.5% per year.
Key information
-42.7%
Earnings growth rate
-45.7%
EPS growth rate
Healthcare Industry Growth | 7.0% |
Revenue growth rate | -4.5% |
Return on equity | -8.1% |
Net Margin | -2.3% |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenues Not Telling The Story For Guangzheng Eye Hospital Group Co.,Ltd. (SZSE:002524) After Shares Rise 28%
Nov 13Guangzheng Eye Hospital Group Co.,Ltd. (SZSE:002524) May Have Run Too Fast Too Soon With Recent 28% Price Plummet
Jun 06Guangzheng Eye Hospital Group Co., Ltd.'s (SZSE:002524) Shares Climb 26% But Its Business Is Yet to Catch Up
Mar 18Revenue & Expenses Breakdown
How Guangzheng Eye Hospital GroupLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 947 | -22 | 342 | 5 |
30 Jun 24 | 1,010 | 5 | 339 | 5 |
31 Mar 24 | 1,058 | -2 | 336 | 5 |
31 Dec 23 | 1,075 | 9 | 329 | 5 |
30 Sep 23 | 1,022 | -200 | 316 | 2 |
30 Jun 23 | 973 | -9 | 308 | 1 |
31 Mar 23 | 798 | -50 | 278 | 1 |
01 Jan 23 | 767 | -78 | 278 | 1 |
30 Sep 22 | 838 | 123 | 284 | 3 |
30 Jun 22 | 858 | -88 | 290 | 3 |
31 Mar 22 | 1,039 | -40 | 322 | 4 |
31 Dec 21 | 1,044 | 37 | 337 | 4 |
30 Sep 21 | 1,082 | 58 | 335 | 2 |
30 Jun 21 | 1,137 | 112 | 340 | 1 |
31 Mar 21 | 1,020 | 69 | 327 | 1 |
31 Dec 20 | 921 | 43 | 283 | 1 |
30 Sep 20 | 913 | -18 | 275 | 0 |
30 Jun 20 | 962 | 54 | 269 | 0 |
31 Mar 20 | 1,086 | 92 | 278 | 0 |
31 Dec 19 | 1,285 | 73 | 309 | 0 |
30 Sep 19 | 1,452 | 56 | 348 | 1 |
30 Jun 19 | 1,518 | -41 | 354 | 1 |
31 Mar 19 | 1,345 | -68 | 301 | 1 |
31 Dec 18 | 1,175 | -75 | 252 | 1 |
30 Sep 18 | 933 | 40 | 178 | 0 |
30 Jun 18 | 638 | 16 | 109 | 0 |
31 Mar 18 | 581 | 7 | 112 | 0 |
31 Dec 17 | 554 | 5 | 106 | 0 |
30 Sep 17 | 497 | -2 | 91 | 0 |
30 Jun 17 | 492 | -3 | 98 | 0 |
31 Mar 17 | 498 | 2 | 90 | 0 |
31 Dec 16 | 499 | 5 | 93 | 0 |
30 Sep 16 | 509 | -36 | 51 | 0 |
30 Jun 16 | 572 | -10 | 53 | 0 |
31 Mar 16 | 551 | -19 | 75 | 0 |
31 Dec 15 | 555 | 6 | 84 | 0 |
30 Sep 15 | 557 | -54 | 156 | 0 |
30 Jun 15 | 541 | -84 | 151 | 0 |
31 Mar 15 | 641 | -58 | 134 | 0 |
31 Dec 14 | 626 | -88 | 120 | 0 |
30 Sep 14 | 615 | -24 | 101 | 0 |
30 Jun 14 | 585 | -6 | 84 | 0 |
31 Mar 14 | 565 | -2 | 73 | 0 |
31 Dec 13 | 505 | 2 | 62 | 0 |
Quality Earnings: 002524 is currently unprofitable.
Growing Profit Margin: 002524 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 002524 is unprofitable, and losses have increased over the past 5 years at a rate of 42.7% per year.
Accelerating Growth: Unable to compare 002524's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 002524 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-5.7%).
Return on Equity
High ROE: 002524 has a negative Return on Equity (-8.12%), as it is currently unprofitable.